Eosinophilic esophagitis (eoe)

Dupilumab is Efficacious Regardless of Endoscopic Phenotype: Post Hoc Analysis of the LIBERTY EoE TREET Study

Dupilumab Maintained Histologic and Endoscopic Improvements During the Open-Label Extension Period of the EoE KIDS Study

Dupilumab in Pediatric EoE: Phase 3 KIDS Study Results

This poster presentation evaluates the efficacy of dupilumab in treating eosinophilic esophagitis (EoE) in patients weighing ≥15 kg at baseline from the Phase 3 KIDS study.